Akouos Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
AKUS Nasdaq 8731 https://akouos.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akouos Inc

Akouos Presents Nonclinical Data Supporting the Planned Clinical Development of AK-OTOF and Strategies for Regulated Gene Expression in the Inner Ear at the American Society of Gene and Cell Therapy 25th Annual Meeting - May 19th, 2022 11:00 am
Akouos Reports First Quarter 2022 Financial Results and Provides Business Highlights - May 12th, 2022 11:45 am
Akouos to Present at Bank of America 2022 Healthcare Conference - May 4th, 2022 11:00 am
Akouos to Present at the American Society of Gene and Cell Therapy 25th Annual Meeting - May 3rd, 2022 11:00 am
Akouos Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights - Mar 29th, 2022 12:00 pm
Akouos to Participate in Upcoming March Virtual Investor Conferences - Mar 24th, 2022 11:00 am
Akouos Appoints Aaron Tward, M.D., Ph.D., as Chief Scientific Officer - Mar 10th, 2022 12:00 pm
Akouos to Present at Cowen 42nd Annual Heath Care Conference - Mar 1st, 2022 12:00 pm
Akouos Presents Nonclinical Data Demonstrating Potential Applicability of Precision Genetic Medicine Platform for a Broad Range of Inner Ear Conditions at the Association for Research in Otolaryngology 45th Annual Mid-Winter Meeting - Feb 7th, 2022 12:00 pm
Akouos to Participate in Upcoming February Virtual Investor Conferences - Jan 31st, 2022 12:00 pm
Akouos to Present at the Association for Research in Otolaryngology 45th Annual Mid-Winter Meeting - Jan 7th, 2022 12:00 pm
We're Hopeful That Akouos (NASDAQ:AKUS) Will Use Its Cash Wisely - Dec 20th, 2021 9:19 am
Akouos to Present at Piper Sandler 33rd Annual Virtual Healthcare Conference - Nov 22nd, 2021 12:00 pm
Akouos Reports Third Quarter 2021 Financial Results and Provides Business Highlights - Nov 12th, 2021 12:00 pm
Akouos Appoints Stacy Price as Chief Technical Officer - Nov 1st, 2021 11:00 am
Boston Named World's Top Biotech Hub as the City's Leading Biotech Companies Continue to Make Major Breakthroughs - Oct 27th, 2021 12:24 pm
Akouos to Present at Jefferies Gene Therapy/Editing Summit - Oct 20th, 2021 11:00 am
Akouos to Present at Upcoming September Virtual Investor Conferences - Sep 7th, 2021 11:00 am
Akouos Reports Second Quarter 2021 Financial Results and Provides Business Highlights - Aug 12th, 2021 11:00 am
Akouos Announces European Commission Designation of AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss as an Orphan Drug - Aug 11th, 2021 11:00 am